A pretty good week, with gains for my biggest holdings resulting in a
narrowing of the deficit between cost and value of £4,880 to £22,604 and an
increase in total portfolio value to £124,911.
The only big loser this week was TLOU:Tlou Energy, which has been on a
good run recently and I think suffered some profit taking. They dropped 9% in
my SIPP and are no longer in profit. I think this needs the PPA to be signed
with the Botswanan government before a real re-rate happens. The share price
is 3p and my options are for 4p so I'm hoping by the time I can take advantage
of them the price will be a lot higher.
ASHM:Ashmore Group climbed by 5% and went back into profit. This is
just quietly being a good magic formula share. The dividend isn't due till
November so I'm hoping they will climb a bit before then so they stay in
profit on ex-dividend day.
CAML:Central Asia Metals regained some of last week's losses with a 6%
rise to go 25% in profit. I wish I had more of these at the current price, but
my sales have enabled a much more diverse portfolio so I think it was the
right thing to do.
FXPO:Ferrexpo also recovered a chunk of last week's losses and
increased by 7%, but such has been the crash over the last few weeks that I am
still 15% down. A nice dividend arrived this week though.
DDDD:4D Pharma is my 2nd largest holding, so much of this week's gains
were due to the 10% climb. I'm still down by 27% but there's some momentum
now, and news is expected soon which should cause a big spike.
Share of the Week is JLP:Jubilee Metals which announced a new deal to
re-open a refinery and fast-track copper earnings in Zambia. That caused an
impressive recovery after the recent slump, and the shares rose by 76% of my
original purchase price to go 304% up.
Much closer to the cost line than the injection line and at the highest value for over 6 months. Thank goodness summer holidays are over!
Soaring above the trend line, but how long can we stay there?
Here's the ISA and shares portfolio after week 4 of year 7.
Huge rise in potential profits of £1,650 all thanks to JLP:Jubilee Metals. a 1p gain in OPTI:Optibiotix contributed to the £3,015 increase in value, as did the big rise in DDDD:4D Pharma. Long term performance slipped another 0.1% to 9.4% so I could do with selling something. I don't want to sell any JLP, so my only real hope is my share account holding of OPTI:Optibiotix which I plan to sell at 84p and transfer the original cash into my trading account and the profits into my ISA. I may do it a little at a time if there's still upwards momentum, as I won't be able to find trading shares to buy with all £2,500 at once. It does mean paying more commission though.
Looking more promising
Trend line is upwards, and we're above it!
The SIPP looks like this after week 300 overall and week 40 of year 6.
Cash increased by £41 thanks the the FXPO:Ferrexpo dividend, portfolio value up by £1,745 mostly thanks to DDDD:4D Pharma and OPTI:Optibiotix, and potential profits only sneaked up by £19 thanks to the big drop in TLOU:Tlou Energy.
Only just above halfway between injection and cost, so quite a way to go.
Back above the trend line, but it's going to take a lot to reverse the direction.
The trading account looks like this after week 266 overall and week 6 of year 6.
One of the best ever weeks, with all shares increasing in value and £121 of my losses got back.
Back on the right side of the injection line but a long, long way to go
| Weekly Change | |||
| Cash | £31.58 |
+£0 | |
| Portfolio cost | £68,170.47 | +£0 | |
| Portfolio sell value (bid price-commission) | £60,030.62 | (-11.9%) | +£3,015.40 |
| Potential profits | £6,574.08 | +£1,650.00 | |
| Yr 7 Dividends | £0 | +£0 | |
| Yr 7 Profit from sales | £0 | +£0 | |
| Yr 7 projected avg monthly profit | £0 | (0%) | +£0 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £24,123.94 | +£0 | |
| Average monthly cash profit |
£345.37 |
(9.4%) | -£1.10 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 57% | +0% |
Huge rise in potential profits of £1,650 all thanks to JLP:Jubilee Metals. a 1p gain in OPTI:Optibiotix contributed to the £3,015 increase in value, as did the big rise in DDDD:4D Pharma. Long term performance slipped another 0.1% to 9.4% so I could do with selling something. I don't want to sell any JLP, so my only real hope is my share account holding of OPTI:Optibiotix which I plan to sell at 84p and transfer the original cash into my trading account and the profits into my ISA. I may do it a little at a time if there's still upwards momentum, as I won't be able to find trading shares to buy with all £2,500 at once. It does mean paying more commission though.
Looking more promising
Trend line is upwards, and we're above it!
The SIPP looks like this after week 300 overall and week 40 of year 6.
| Weekly Change | ||||
| Cash | £338.33 | +£41.81 | ||
| Portfolio cost | £76,342.81 | +£0 | ||
|
Portfolio sell value (bid price - commission) |
£62,861.97 | (-17.7%) | +£1,745.01 | |
| Potential profits | £369.26 | +£19.98 | ||
| Yr 6 Dividends | £944.58 | +£41.81 | ||
| Yr 6 Interest | £0 | +£0 | ||
| Yr 6 Profit from sales | £8,345.60 | +£0 | ||
| Yr 6 projected avg monthly profit | £990.09 | (25.9%) | -£20.75 | |
| Total Dividends | £3,011.66 | +£41.81 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £23,805.04 | +£0 | ||
| Average monthly cash profit | £376.21 | (9.8%) | -£0.65 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 57% | +0% |
Cash increased by £41 thanks the the FXPO:Ferrexpo dividend, portfolio value up by £1,745 mostly thanks to DDDD:4D Pharma and OPTI:Optibiotix, and potential profits only sneaked up by £19 thanks to the big drop in TLOU:Tlou Energy.
Only just above halfway between injection and cost, so quite a way to go.
Back above the trend line, but it's going to take a lot to reverse the direction.
The trading account looks like this after week 266 overall and week 6 of year 6.
| Weekly Change | |||
| Cash | £259.74 | +£0 | |
| Portfolio cost | £2,374.14 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,389.94 | (-41.5%) | +£121.43 |
| Potential profits | £0.00 | +£0 | |
| Year 6 Dividends | £0.00 | +£0 | |
| Year 6 Profit | £0.00 | +£0 | |
| Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £937.88 | +£0 | |
| Average monthly cash profit | £16.26 | (8.2%) | -£0.06 |
|
(Sold stocks profit + Dividends - Fees / Months) |
One of the best ever weeks, with all shares increasing in value and £121 of my losses got back.
Back on the right side of the injection line but a long, long way to go
Although it was a good week, we're still well below the trend line, but it's
September now and news is expected for DDDD:4D Pharma, and
HUM:Hummingbird Resources may benefit if there's a bullish run on
gold miners. Still looking hopeless for IQE:IQE, and if their recent
newsletter is to be believed, TALY:Tally should re-list in
December.
I just had a look at my SIPP portfolio and I'm now up to 10 magic formula shares, all paying good dividends. There seems to be a rush of them in October, so something to looks forward to. Only 3 of the 10 are in profit, so I'm not doing as well as last year, but the earliest review date is the end of May next year, so there's plenty of time. Currently £10,000 worth of shares are down by £865, but most of those losses are down to the recent bear run on miners.
I just had a look at my SIPP portfolio and I'm now up to 10 magic formula shares, all paying good dividends. There seems to be a rush of them in October, so something to looks forward to. Only 3 of the 10 are in profit, so I'm not doing as well as last year, but the earliest review date is the end of May next year, so there's plenty of time. Currently £10,000 worth of shares are down by £865, but most of those losses are down to the recent bear run on miners.
Last year's batch made me £2,500 profit from 5 companies costing £5,000 so a
pretty staggering 50%, along with an additional £384 in dividends, which is
7.6%. Given ITV:ITV didn't pay a dividend, the return from
dividend-paying companies was actually 9.6%. If I can get anywhere near that
sort of performance with my new batch then I'd be able to say the formula is
working.
No comments:
Post a Comment